Insilico Medicine’s $80 Million Agreement with Exelixis

Wilson Sonsini Goodrich & Rosati advised Insilico Medicine on the transaction.Exelixis, Inc. and Insilico Medicine announced that they have entered into an exclusive license agreement granting Exelixis global…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here